Intelligence · Clinical Development
Pipeline search results
Programs matching “paclitaxel” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 72 pipeline programs matching "paclitaxel" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
L2023-K003-002
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
NJMU-BC01
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Nab paclitaxel
BRIGHT MINDS BIOSCIENCES INC.
Metastatic Pancreatic Cancer
1 trial -
Nab-paclitaxel
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Head and Neck Squamous Cell Carcinoma
1 trial -
Nab-paclitaxel Combined With Cadonilimab (AK104)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
PACLITAXEL AHCL /ml for Head and neck squamous cell carcinoma
Ningbo Cancer Hospital
Head and neck squamous cell carcinoma
1 trial -
Paclitaxel
Cardiff Oncology
Carcinosarcoma
1 trial -
Paclitaxel
ONCOLYTICS BIOTECH INC
Metastatic Breast Cancer
1 trial -
Paclitaxel
ONCOLYTICS BIOTECH INC
Breast Cancer Metastatic
1 trial -
Paclitaxel
Takeda
Ovarian Cancer
1 trial -
Paclitaxel
Jazz Pharmaceuticals Ireland Limited
Gastroesophageal Adenocarcinoma
1 trial -
Paclitaxel
PUMA BIOTECHNOLOGY, INC.
Breast Cancer
1 trial -
Paclitaxel
CNS Pharmaceuticals
Ovarian Cancer
1 trial -
Paclitaxel
United Therapeutics Europe Ltd
Clinical Stage III Gastric Cancer AJCC v8
1 trial -
Paclitaxel
Takeda
Endometrial Neoplasms
1 trial -
Paclitaxel
Merck KGaA, Darmstadt, Germany
Esophageal Squamous Cell Carcinoma
1 trial -
Paclitaxel /ml Concentrate for Resectable Locally Advanced Ora…
Fondazione Telethon ETS
Resectable Locally Advanced Oral Cavity Squamous Cell Carcinoma
1 trial -
Paclitaxel and TAK-228
Takeda
Metastatic Urothelial Cancer
1 trial -
Relacorilant with nab-paclitaxel
CORCEPT THERAPEUTICS INC
Solid Tumors
1 trial -
Rituximab Paclitaxel Ruxolitinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Refractory Diffuse Large B-cell Lymphoma
1 trial -
Sintilimab,nab-paclitaxel and tegio
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Surufatinib + Serplulimab+Albumin-paclitaxel + Gemcitabine
Sun Yat-sen University
Locally Advanced Pancreatic Cancer
1 trial -
Toripalimab+Nedaplatin+Albumin Paclitaxel
The First People's Hospital of Lianyungang
Locally Advanced Esophageal Squamous Cell Carcinoma
1 trial -
anlotinib+TQB2450+nab-paclitaxel+cisplatin
The First People's Hospital of Lianyungang
Advanced Biliary Tract Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.